Regulation of interleukin-6 expression by arecoline in human buccal mucosal fibroblasts is related to intracellular glutathione levels

Oral Diseases

Volumn 10, Issue 6, 2004, Pages 360-364

  Tsai, C H ^a   Yang, S F ^b   Chen, Y J ^a   Chu, S C ^c   Hsieh, Y S ^b   Chang, Y C ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

Author keywords

Arecoline; Buccal mucosal fibroblasts; Glutathione; Interleukin 6; Oral submucous fibrosis

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; ARECOLINE; BUTHIONINE SULFOXIMINE; GLUTATHIONE; INTERLEUKIN 6; MESSENGER RNA;

ARTICLE; CELL CULTURE; CELL FUNCTION; CHEEK MUCOSA; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBROBLAST; FIBROSIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; SCAR FORMATION; UPREGULATION;

ARECA; ARECOLINE; BUTHIONINE SULFOXIMINE; FIBROBLASTS; GLUTATHIONE; HUMANS; INTERLEUKIN-6; MALE; ORAL SUBMUCOUS FIBROSIS; POLYMERASE CHAIN REACTION; PYRROLIDONECARBOXYLIC ACID; RNA, MESSENGER; THIAZOLES; THIAZOLIDINES; UP-REGULATION;

EID: 9444236177     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2004.01041.x     Document Type: Article

References (35)

1. Belazi M, Thomopolos GN, Markopoulos AK, Papanaytou P (1993). Cyclosporin-A induced gingival hyperplasia: an ultrastructural study of its oral epithelial prickle cells. J Submicro Cytol Pathol 25: 591-601.
2. Chang YC, Tai KW, Cheng MH, Chou LSS, Chou MY (1998). Cytotoxic and non-genotoxic effects of arecoline on human buccal fibroblasts in vitro. J Oral Pathol Med 27: 68-71.
3. Chang YC, Tai KW, Chou MY, Tseng TH (2000). Synergistic effects of peroxynitrite on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts. Toxicol Lett 118: 61-68.
4. Chang YC, Hu CC, Tseng TH, Tai KW, Lu CK, Chou MY (2001). Synergistic effects of nicotine on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts. J Oral Pathol Med 30: 458-464.
5. Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS (2002a). Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol 38: 195-200.
6. Chang YC, Tsai CH, Tai KW, Yang SH, Chou MY, Lii CK (2002b). Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 38: 425-430.
7. Chatterjee A, Deb S (1999). Gentotoxic effect of arecoline given either by the pertioneal or routine in murine bone marrow cells and the influence of N-acetylcysteine. Cancer Lett 139: 23-31.
8. Chen CC, Huang JF, Tsai CC (1995). In vitro production of interleukin-6 by human gingival, normal buccal mucosa, and oral submucous fibrosis fibroblasts treated with betel-nut alkaloids. Kaohsiung J Med Sci 11: 604-614.
9. Deb S, Chatterjee A (1998). Influence of buthionine sulfoximine and reduced glutathione on arecoline-induced chromosomal damage and sister chromatid exchange in mouse bone marrow cells in vivo. Mutagenesis 13: 243-248.
10. Greenwel P, Iraburu MJ, Reyesromero M et al (1995). Induction of an acute-phase response in rats stimulates the expression of alpha-I procollagen messenger ribonucleic acid in their livers; possible role of interleukin-6. Lab Invest 72: 83-91.
11. Grossman RM, Krueger J, Yourish D et al (1989). Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86: 6367-6371.
12. Haque MF, Harris M, Meghji S. Barrett AW (1998). Immunolocalization of cytokines and growth factors in oral submucous fibrosis. Cytokine 10: 713-719.
13. Haque MF, Meghji S, Khitab U, Harris M (2000). Oral submucous fibrosis patients have altered levels of cytokine production. J Oral Pathol Med 29: 123-128.
14. Harvey W, Scutt A, Meghji S, Canniff JP (1986). Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. Arch Oral Biol 31: 45-49.
15. Hasegawa M, Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K (1998). Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis. J Rheumatol 25: 308-313.
16. Jeng JH, Tsai CL, Hahn LJ et al (1999). Arecoline cytotoxicity on human oral mucosal fibroblasts related to cellular thiol and esterase activities. Food Chem Toxicol 37: 751-756.
17. Jeng JH, Wang YJ, Chiang BL et al (2003). Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-α production of oral epithelial cells by areca nut extract and arecoline. Carcinogensis 24: 1301-1305.
18. Koracs EJ (1991). Fibrogenic cytokines the role of immune mediators in the development of scar tissue. Immunol Today 12: 17-23.
19. Kuo MYP, Chen HM, Hahn LJ, Hsieh CC, Chiang CP (1995). Collagen biosynthesis in human oral submucous fibrosis fibroblast cultures. J Dent Res 74: 1783-1788.
20. Lotz M, Guerne PA (1991). Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinase-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 266: 2017-2120.
21. Ma RH, Tsai CC, Shieh TY (1995). Increased lysyl oxidase activity in fibroblasts cultured from oral submucous fibrosis associated with betel nut chewing in Taiwan. J Oral Pathol Med 24: 407-412.
22. Maher R, Lee AJ, Warnakulasuriya KAAS, Lewis JA, Johnson NW (1994). Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan. J Oral Pathol Med 23: 65-69.
23. Mantovani G, Maccio A, Madeddu C et al (2003). The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression. Free Radical Res 37: 213-223.
24. Meister (1983). Selective modification of glutathione metabolism. Science 220: 472-477.
25. Meister A, Anderson M (1983). Glutathione. Annu Rev Biochem 52: 711-760.
26. Mutri PR, Bhonsle RB, Gupta PC, Daftary DK, Pindborg JJ, Mehta FS (1995). Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing. J Oral Pathol Med 24: 145-152.
27. Roth M, Nauck M, Tamm M, Perruchoud AP, Ziesche R, Block LH (1995). Intracellular interleukin-6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells. Proc Natl Acad Sci USA 92: 1312-1316.
28. Sato T, Ito A, Mori Y (1990). Interleukin-6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. Biochem Biophy Res Commun 170: 824-829.
29. Sinor PN, Gupta PC, Murti PR et al (1990). A case-control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med 19: 94-98.
30. Trivedy C, Warnakulasuriya KAAS, Hazarey VK, Tavassoli M, Sommer P, Johnson NW (1999). The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma. J Oral Pathol Med 28: 246-251.
31. Tsai CH, Chou MY, Chang YC (2003). The upregulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med 32: 146-153.
32. Williamson JM, Boettcher B, Meister A (1982). Intracellilar cysteine delivery system that protects against toxicity by promoting glutathione synthesis. Proc Natl Acad Sci USA 79: 6246-6249.
33. Wong DYK, Hsiao YL, Poon CK et al (1994). Glutathione concentration in oral cancer tissues. Cancer Lett 81: 111-116.
34. Yang SF, Hsieh YS, Tsai CH, Chou MY, Chang YC (2003a). The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. Oral Oncol 39: 367-372.
35. Yang LC, Tsai CH, Huang FM, Liu CM, Lai CC, Chang YC (2003b). Induction of interleukin-6 gene expression by pro-inflammatory cytokines and black-pigmented Bacteroides in human pulp cell cultures. Int Endodon J 36: 352-357.